Ann: Starpharma completes US New Drug Application for VivaGel BV, page-30

Well now we know why the submission took as long as it did. 110 000 pages is no mean feat. I realise it has been a long, hard slog for some of us however it is now in the hands of the fda. With the application refund they gave to us I think it’s s foregone conclusion that everything will be pushed through ASAP. My hope now is that SPL get all processes in place with partners etc to hit the ground running in the US once vivagel is given the ok. I’m thinking on the shelves by March next year would be nice. Once the product is available for sale, with a 1.75billion market ready for the taking, it’s hard to think that SPL still only has a market cap of sub 500million. And that’s just the vivagel portfolio. Exciting times ahead folks. Years of hard work are about to pay off. Gltah